Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Med Genet
2020 Apr 01;574:283-288. doi: 10.1136/jmedgenet-2019-106273.
Show Gene links
Show Anatomy links
De novo variants in SLC12A6 cause sporadic early-onset progressive sensorimotor neuropathy.
Park J, Flores BR, Scherer K, Kuepper H, Rossi M, Rupprich K, Rautenberg M, Deininger N, Weichselbaum A, Grimm A, Sturm M, Grasshoff U, Delpire E, Haack TB.
???displayArticle.abstract???
BACKGROUND: Charcot-Marie-Tooth disease (CMT) is a clinically and genetically heterogeneous disorder of the peripheral nervous system. Biallelic variants in SLC12A6 have been associated with autosomal-recessive hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC). We identified heterozygous de novo variants in SLC12A6 in three unrelated patients with intermediate CMT.
METHODS: We evaluated the clinical reports and electrophysiological data of three patients carrying de novo variants in SLC12A6 identified by diagnostic trio exome sequencing. For functional characterisation of the identified variants, potassium influx of mutated KCC3 cotransporters was measured in Xenopus oocytes.
RESULTS: We identified two different de novo missense changes (p.Arg207His and p.Tyr679Cys) in SLC12A6 in three unrelated individuals with early-onset progressive CMT. All presented with axonal/demyelinating sensorimotor neuropathy accompanied by spasticity in one patient. Cognition and brain MRI were normal. Modelling of the mutant KCC3 cotransporter in Xenopus oocytes showed a significant reduction in potassium influx for both changes.
CONCLUSION: Our findings expand the genotypic and phenotypic spectrum associated with SLC12A6 variants from autosomal-recessive HMSN/ACC to dominant-acting de novo variants causing a milder clinical presentation with early-onset neuropathy.
???displayArticle.pubmedLink???
31439721 ???displayArticle.pmcLink???PMC11074718 ???displayArticle.link???J Med Genet ???displayArticle.grants???[+]
Adragna,
Regulated phosphorylation of the K-Cl cotransporter KCC3 is a molecular switch of intracellular potassium content and cell volume homeostasis.
2015, Pubmed
Adragna,
Regulated phosphorylation of the K-Cl cotransporter KCC3 is a molecular switch of intracellular potassium content and cell volume homeostasis.
2015,
Pubmed Berciano,
Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
2017,
Pubmed Byun,
Axonal and periaxonal swelling precede peripheral neurodegeneration in KCC3 knockout mice.
2007,
Pubmed Delpire,
Housing and husbandry of Xenopus laevis affect the quality of oocytes for heterologous expression studies.
2011,
Pubmed
,
Xenbase Ding,
A trafficking-deficient mutant of KCC3 reveals dominant-negative effects on K-Cl cotransport function.
2013,
Pubmed
,
Xenbase Fassio,
De novo mutations of the ATP6V1A gene cause developmental encephalopathy with epilepsy.
2018,
Pubmed Flores,
A role for KCC3 in maintaining cell volume of peripheral nerve fibers.
2019,
Pubmed Fritzen,
De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies.
2018,
Pubmed Gagnon,
Physiology of SLC12 transporters: lessons from inherited human genetic mutations and genetically engineered mouse knockouts.
2013,
Pubmed Howard,
The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum.
2002,
Pubmed
,
Xenbase Kahle,
Peripheral motor neuropathy is associated with defective kinase regulation of the KCC3 cotransporter.
2016,
Pubmed Kong,
Rate of de novo mutations and the importance of father's age to disease risk.
2012,
Pubmed Nicholson,
Intermediate forms of Charcot-Marie-Tooth neuropathy: a review.
2006,
Pubmed Pearson,
Localization of the K(+)-Cl(-) cotransporter, KCC3, in the central and peripheral nervous systems: expression in the choroid plexus, large neurons and white matter tracts.
2001,
Pubmed Rinehart,
Sites of regulated phosphorylation that control K-Cl cotransporter activity.
2009,
Pubmed Rossor,
Clinical implications of genetic advances in Charcot-Marie-Tooth disease.
2013,
Pubmed Rudnik-Schöneborn,
Andermann syndrome can be a phenocopy of hereditary motor and sensory neuropathy--report of a discordant sibship with a compound heterozygous mutation of the KCC3 gene.
2009,
Pubmed Shekarabi,
Cellular expression of the K+-Cl- cotransporter KCC3 in the central nervous system of mouse.
2011,
Pubmed Tazir,
Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update.
2014,
Pubmed Uyanik,
Novel truncating and missense mutations of the KCC3 gene associated with Andermann syndrome.
2006,
Pubmed Veltman,
De novo mutations in human genetic disease.
2012,
Pubmed
